Literature DB >> 16793546

Comparative analysis identifies exonic splicing regulatory sequences--The complex definition of enhancers and silencers.

Amir Goren1, Oren Ram1, Maayan Amit1, Hadas Keren1, Galit Lev-Maor1, Ida Vig1, Tal Pupko2, Gil Ast3.   

Abstract

Exonic splicing regulatory sequences (ESRs) are cis-acting factor binding sites that regulate constitutive and alternative splicing. A computational method based on the conservation level of wobble positions and the overabundance of sequence motifs between 46,103 human and mouse orthologous exons was developed, identifying 285 putative ESRs. Alternatively spliced exons that are either short in length or contain weak splice sites show the highest conservation level of those ESRs, especially toward the edges of exons. ESRs that are abundant in those subgroups show a different distribution between constitutively and alternatively spliced exons. Representatives of these ESRs and two SR protein binding sites were shown, experimentally, to display variable regulatory effects on alternative splicing, depending on their relative locations in the exon. This finding signifies the delicate positional effect of ESRs on alternative splicing regulation.

Entities:  

Mesh:

Year:  2006        PMID: 16793546     DOI: 10.1016/j.molcel.2006.05.008

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  164 in total

Review 1.  The interface of protein structure, protein biophysics, and molecular evolution.

Authors:  David A Liberles; Sarah A Teichmann; Ivet Bahar; Ugo Bastolla; Jesse Bloom; Erich Bornberg-Bauer; Lucy J Colwell; A P Jason de Koning; Nikolay V Dokholyan; Julian Echave; Arne Elofsson; Dietlind L Gerloff; Richard A Goldstein; Johan A Grahnen; Mark T Holder; Clemens Lakner; Nicholas Lartillot; Simon C Lovell; Gavin Naylor; Tina Perica; David D Pollock; Tal Pupko; Lynne Regan; Andrew Roger; Nimrod Rubinstein; Eugene Shakhnovich; Kimmen Sjölander; Shamil Sunyaev; Ashley I Teufel; Jeffrey L Thorne; Joseph W Thornton; Daniel M Weinreich; Simon Whelan
Journal:  Protein Sci       Date:  2012-04-23       Impact factor: 6.725

2.  Changes in exon-intron structure during vertebrate evolution affect the splicing pattern of exons.

Authors:  Sahar Gelfman; David Burstein; Osnat Penn; Anna Savchenko; Maayan Amit; Schraga Schwartz; Tal Pupko; Gil Ast
Journal:  Genome Res       Date:  2011-10-05       Impact factor: 9.043

3.  The Silent Sway of Splicing by Synonymous Substitutions.

Authors:  William F Mueller; Liza S Z Larsen; Angela Garibaldi; G Wesley Hatfield; Klemens J Hertel
Journal:  J Biol Chem       Date:  2015-09-30       Impact factor: 5.157

Review 4.  The RNAissance family: SR proteins as multifaceted regulators of gene expression.

Authors:  Jonathan M Howard; Jeremy R Sanford
Journal:  Wiley Interdiscip Rev RNA       Date:  2014-08-22       Impact factor: 9.957

5.  Modeling the human MTM1 p.R69C mutation in murine Mtm1 results in exon 4 skipping and a less severe myotubular myopathy phenotype.

Authors:  Christopher R Pierson; Ashley N Dulin-Smith; Ashley N Durban; Morgan L Marshall; Jordan T Marshall; Andrew D Snyder; Nada Naiyer; Jordan T Gladman; Dawn S Chandler; Michael W Lawlor; Anna Buj-Bello; James J Dowling; Alan H Beggs
Journal:  Hum Mol Genet       Date:  2011-11-07       Impact factor: 6.150

6.  Widespread mRNA polyadenylation events in introns indicate dynamic interplay between polyadenylation and splicing.

Authors:  Bin Tian; Zhenhua Pan; Ju Youn Lee
Journal:  Genome Res       Date:  2007-01-08       Impact factor: 9.043

7.  Loss of exon identity is a common mechanism of human inherited disease.

Authors:  Timothy Sterne-Weiler; Jonathan Howard; Matthew Mort; David N Cooper; Jeremy R Sanford
Journal:  Genome Res       Date:  2011-07-12       Impact factor: 9.043

8.  Rational design of antisense oligomers to induce dystrophin exon skipping.

Authors:  Chalermchai Mitrpant; Abbie M Adams; Penny L Meloni; Francesco Muntoni; Sue Fletcher; Steve D Wilton
Journal:  Mol Ther       Date:  2009-03-17       Impact factor: 11.454

9.  Quantitative analysis of clinically relevant mutations occurring in lymphoid cells harboring gamma-retrovirus-encoded hsvtk suicide genes.

Authors:  X Wang; M Olszewska; V Capacio; J Stefanski; M Przybylowski; S Samakoglu; A H Chang; M Sadelain; I Rivière
Journal:  Gene Ther       Date:  2008-06-19       Impact factor: 5.250

10.  Alternative splicing attenuates transgenic expression directed by the apolipoprotein E promoter-enhancer based expression vector pLIV11.

Authors:  Dongmei Cheng; Philip S MacArthur; Shunxing Rong; John S Parks; Gregory S Shelness
Journal:  J Lipid Res       Date:  2009-10-27       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.